Pulmonary Diseases: Clinical Trials

1 trial for Pulmonary Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Pulmonary Diseases: new trials by email Literature Review of Pulmonary Diseases trials Research Report on Pulmonary Diseases

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease
Addition of clarithromycin to rifampicin and ethambutol, Addition of Ciprofloxacin to rifampicin and ethambutol, Vaccination with M.vaccae - Pulmonary Diseases
Phase 4CompletedBritish Thoracic Society4001995-03-012006-08-23

Narrower conditions

Lung Diseases (1)

Broader conditions

Respiratory Tract Diseases (1)

Interventions

Ethambutol (1)  ·  Vaccination (1)

Sponsors

British Thoracic Society (1)

Countries

United Kingdom (1)

Top investigators

Ian Campbell, BSc MD FRCP (1)